Accès gratuit
Numéro
Med Sci (Paris)
Volume 18, Numéro 3, Mars 2002
Page(s) 303 - 314
Section M/S Revues : Articles de Synthèse
DOI http://dx.doi.org/10.1051/medsci/2002183303
Publié en ligne 15 mars 2002
  1. Honda M, Beard MR, Ping LH, Lemon SM. A phylogenetically conserved stem-loop structure at the 5’ border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation. J Virol 1999; 73 : 1165–74.
  2. Kholykalov AA, Feinstone SM, Rice CM. Identification of a highly conserved sequence element at the 3’ terminus of hepatitis C virus genome RNA. J Virol 1996; 70 : 336–71.
  3. Penin F, Combet C, Germanidis G, Frainais PO, Deleage G, Pawlotsky JM. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. J Virol 2001; 75 : 5703–10.
  4. Pileri P, Uematsu Y, Campagnoli S, et al. Binding of hepatitis C virus to CD81. Science 1998; 282 : 938–41.
  5. Wunschmann S, Medh JD, Klinzmann D, Schmidt WN, Stapleton JT. Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J Virol 2000; 74 : 10055–62.
  6. Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA 1999; 96 : 12766–71.
  7. Tsukiyama-Kohara K, Iizuka N, Kohara M, Nomoto A. Internal ribosome entry site within hepatitis C virus RNA. J Virol 1992; 66 : 1476–83.
  8. Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice CM. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 1993; 67 : 1385–95.
  9. Dubuisson J, Hsu HH, Cheung RC, Greenberg HB, Russell DG, Rice CM. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol 1994; 68 : 6147–60.
  10. Grakoui A, McCourt DW, Wychowski C, Feinstone SM, Rice CM. A second hepatitis C virus-encoded proteinase. Proc Natl Acad Sci USA 1993; 90 : 10583–7.
  11. Satoh S, Hirota M, Noguchi T, Hijikata M, Handa H, Shimotohno K. Cleavage of hepatitis C virus nonstructural protein 5A by a caspase-like protease(s) in mammalian cells. Virology 2000; 270 : 476–87.
  12. Ishido S, Fujita T, Hotta H. Complex formation of NS5B with NS3 and NS4A proteins of hepatitis C virus. Biochem Biophys Res Commun 1998; 244 : 35–40.
  13. Hussy P, Langen H, Mous J, Jacobsen H. Hepatitis C virus core protein: carboxyterminal boundaries of two processed species suggest cleavage by a signal peptide peptidase. Virology 1996; 224 : 93–104.
  14. Ray RB, Lagging LM, Meyer K, Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 1996; 70 : 4438–43.
  15. Moriya K, Fujie H, Shintani Y, , et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998; 4 : 1065–7.
  16. Sabile A, Perlemuter G, Bono F, et al. Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology 1999; 30 : 1064–76.
  17. Farci P, Alter HJ, Wong DC, et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci USA 1994; 91 : 7792–6.
  18. Dubuisson J, Hsu HH, Cheung RC, Greenberg HB, Russell DG, Rice CM. Formation and intracellular localization of hepatitis C virus glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol 1994; 68 : 6147–60.
  19. Deleersnyder V, Pillez A, Wychowski C, et al. Formation of native hepatitis C virus glycoprotein complexes. J Virol 1997; 71 : 697–704.
  20. Hijikata M, Mizushima H, Akagi T, et al. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol 1993; 67 : 4665–75.
  21. De Francesco R, Urbani A, Nardi MC, Tomei L, Steinkhuler C, Tramontano A. A zinc binding site in viral serine proteinases. Biochemistry 1996; 35 : 13282–7.
  22. Love RA, Parge HE, Wickersham JA, et al. The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell 1996; 87 : 331–42.
  23. Kim JL, Morgenstern KA, Griffith JP, et al. Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding. Structure 1998; 6 : 89–100.
  24. Kim DW, Gwack Y, Han JH, Choe J. Towards defining a minimal functional domain for NTPase and RNA helicase activities of the hepatitis C virus NS3 protein. Virus Res 1997; 49 : 17–25.
  25. Yao N, Hesson T, Cable M, et al. Structure of the hepatitis C virus RNA helicase domain. Nat Struct Biol 1997; 4 : 463–7.
  26. Kim JL, Morgenstern KA, Griffith JP, et al. Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding. Structure 1998; 6 : 89–100.
  27. Hugle T, Fehrmann F, Bieck E, et al. The hepatitis C virul nonstructural protein 4B is an integral endoplasmic reticulum membrane protein. Virology 2001; 284 : 70–81.
  28. Reed KE, Xu J, Rice CM. Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5Aassociated kinase. J Virol 1997; 71 : 7187–97.
  29. Polyak SJ, Paschal DM, McArdle S, Gale MJ Jr, Moradpour D, Gretch DR. Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferonsensitive virus replication. Hepatology 1999; 29 : 1262–71.
  30. Kato N, Lan KH, Ono-Nita SK, Shiratori Y, Omata M. Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator. J Virol 1997; 71 : 8856–9.
  31. Gale M Jr, Kwieciszewski B, Dossett M, Nakao H, Katze MG. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J Virol 1999; 73 : 6506–16.
  32. Behrens SE, Tomei L, De Francesco R. Identification and properties of the RNAdependent RNA polymerase of hepatitis C virus. EMBO J 1996; 15 : 12–22.
  33. Lohmann V, Korner F, Herian U, Bartenschlager R. Biochemical properties of hepatitis C virus NS5B RNAdependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity. J Virol 1997; 71 : 8416–28.
  34. Bressanelli S, Tomei L, Roussel A, et al. Crystal structure of the RNAdependent RNA polymerase of hepatitis C virus. Proc Natl Acad Sci USA 1999; 96 : 13034–9.
  35. Neumann AU, Lam NP, Dahari H, et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 1998; 282 : 103–7.
  36. Dahari H, Major M, Mihalik K, Feinstone S, Neumann AU. Lack of virus cytopathicity but strong IFN and cellular immune responses during primary HCV infection in chimpanzees. Hepatology 2000; 32 : 302A.
  37. Robertson B, Myers G, Howard C, et al. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses : proposal for standardization. Arch Virol 1998; 143 : 2493–503.
  38. Simmonds P, Smith DB. Structural constraints on RNA virus evolution. J Virol 1999; 73 : 5787–94.
  39. Pybus OG, Charleston MA, Gupta S, Rambaut A, Holmes EC, Harvey PH. The epidemic behavior of the hepatitis C virus. Science 2001; 292 : 2323–5.
  40. Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, et al. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995; 171 : 1607–10.
  41. Pawlotsky JM, De Gendt S, Beaucourt S, et al. Worldwide spread of hepatitis C virus genotype 3a among intravenous drug users. Hepatology 1998; 28 : 563A.
  42. Martell M, Esteban JI, Quer J, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992; 66 : 3225–9.
  43. Pawlotsky JM, Germanidis G, Frainais PO, et al. Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy. J Virol 1999; 73 : 6490–9.
  44. Pawlotsky JM, Germanidis G, Neumann AU, Pellerin M, Frainais PO, Dhumeaux D. Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations. J Virol 1998; 72 : 2795–805.
  45. Navas S, Martin J, Quiroga JA, Castillo I, Carreno V. Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients. J Virol 1998; 72 : 1640–6.
  46. Afonso AM, Jiang J, Penin F, et al. Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets. J Virol 1999; 73 : 9213–21.
  47. Shimizu YK, Igarashi H, Kanematu T, et al. Sequence analysis of the hepatitis C virus genome recovered from serum, liver, and peripheral blood mononuclear cells of infected chimpanzees. J Virol 1997; 71 : 5769–73.
  48. Lerat H, Rumin S, Habersetzer F, et al. In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood 1998; 91 : 3841–9.
  49. Bain C, Fatmi A, Zoulim F, Zarski JP, Trepo C, Inchauspe G. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 2001; 120 : 512–24.
  50. Laporte J, Malet I, Andrieu T, et al. Comparative analysis of translation efficiencies of hepatitis C virus 5’ untranslated regions among intraindividual quasispecies present in chronic infection: opposite behaviors depending on cell type. J Virol 2000; 74 : 10827–33.
  51. Mercer DF, Schiller DE, Elliott JF, et al. Hepatitis C virus replication in mice with chimeric human livers. Nat Med 2001; 7 : 927–33.
  52. Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999; 285 : 110–3.